"Urology of Virginia (UVA) has a long history of providing comprehensive and quality care to the entire Hampton Roads region, including northeastern North Carolina. Whether you come to us with kidney, urinary tract, prostate, pelvic or other urological needs, you’ll find our providers well-versed in delivering the most customized programs and treatment plans. Our clinical care team consists of 32 board certified urologists, most of whom are fellowship trained, nationally recognized, awarded and published. More importantly, they are dedicated to providing superior care and individualized attention to their patients. Included in the team are a specialty trained GU pathologist, physician assistants, nurse practitioners, RN’s, x-ray."

During the past decade, Urology of Virginia conducted 58 clinical trials. In the 10-year time frame, 58 clinical trials started and 38 clinical trials were completed, i.e. on average, 65.5% percent of trials that started reached the finish line to date. In the past 5 years, 22 clinical trials started and 21 clinical trials were completed. i.e. 95.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Urology of Virginia" #1 sponsor was "Dendreon" with 10 trials, followed by "Ferring Pharmaceuticals" with 9 trials sponsored, "Janssen Research & Development, LLC" with 7 trials sponsored, "Allena Pharmaceuticals" with 5 trials sponsored and "Pfizer" with 5 trials sponsored. Other sponsors include 49 different institutions and companies that sponsored additional 44 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Urology of Virginia" #1 collaborator was "Astellas Pharma Inc" with 5 trials as a collaborator, "Medivation LLC, a wholly owned subsidiary of Pfizer Inc." with 4 trials as a collaborator, "Urology of Virginia" with 2 trials as a collaborator, "Allergan" with 1 trials as a collaborator and "ClinLogix. LLC" with 1 trials as a collaborator. Other collaborators include 3 different institutions and companies that were collaborators in the rest 13 trials.

According to Clinical.Site data, the most researched conditions in "Urology of Virginia" are "Prostate Cancer" (23 trials), "Stress Urinary Incontinence" (7 trials), "Bladder Cancer" (5 trials), "Kidney Stones" (4 trials) and "Overactive Bladder" (4 trials). Many other conditions were trialed in "Urology of Virginia" in a lesser frequency.

Most popular intervention types in "Urology of Virginia" are "Drug" (57 trials), "Biological" (16 trials), "Device" (16 trials), "Other" (7 trials) and "Diagnostic Test" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (19 trials), "Degarelix" (6 trials), "Enzalutamide" (6 trials), "sipuleucel-T" (4 trials) and "Leuprolide" (3 trials). Other intervention names were less common.

The vast majority of trials in "Urology of Virginia" are 53 trials for "Male" genders, 28 trials for "All" genders and 9 trials for "Female" genders.

Currently, there are NaN active trials in "Urology of Virginia". undefined are not yet recruiting, 6 are recruiting, 17 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 49 completed trials in Urology of Virginia, undefined suspended trials, and 16 terminated clinical trials to date.

Out of the total trials that were conducted in Urology of Virginia, 7 "Phase 1" clinical trials were conducted, 24 "Phase 2" clinical trials and 31 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 7 trials, and there were also 16 trials that are defined as “Not Applicable".

Urology of Virginia has several departments that took part in Clinical trials: "Devine Tidewater Urology" - 5 trials